Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Duchenne Muscular Dystrophy Clinical Trials
Duchenne Muscular Dystrophy clinical trials are recruiting across 55 cities. Here are the cities with the most active studies:
Duchenne Muscular Dystrophy Trial Phases
34 research organizations are sponsoring duchenne muscular dystrophy trials.
About Duchenne Muscular Dystrophy
Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.
Clinical trials are advancing new treatments for duchenne muscular dystrophy. Currently, 39 studies are recruiting a combined 25,582 participants across the United States. Research is being conducted by 34 organizations including The Duchenne Registry, CureDuchenne, Cure CMD and 31 others.
2026 Duchenne Muscular Dystrophy Research Landscape
As of July 2026, the duchenne muscular dystrophy clinical trial landscape includes 39 actively recruiting studies across 55 cities in the United States. These studies are collectively seeking 25,582 participants, with an average enrollment target of 656 per study.
The research spans multiple phases of development: 12 studies are in PHASE1, 10 studies are in PHASE2, 5 studies are in PHASE3, 1 study is in NA, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some duchenne muscular dystrophy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 34 different organizations, including The Duchenne Registry, CureDuchenne, Cure CMD, Vanderbilt University Medical Center, University of Florida, and 29 others. The large number of sponsors reflects significant research interest and investment in duchenne muscular dystrophy treatment advancement.
Geographically, duchenne muscular dystrophy trials are most concentrated in Little Rock, Arkansas (11 trials); Chicago, Illinois (9 trials); Atlanta, Georgia (8 trials); Iowa City, Iowa (8 trials); Columbus, Ohio (7 trials) and 7 other cities.
Featured Duchenne Muscular Dystrophy Studies
Highlighted recruiting studies for duchenne muscular dystrophy, selected by enrollment size and research scope.
The Duchenne Registry
The Duchenne Registry is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of the Registry is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, The Duchenne Registry is ...
CureDuchenne Link®: A Resource for Research
CureDuchenne link is a data hub comprised of integrated biospecimens, clinical data, and self- and/or caregiver-reported information from participants. Anyone over 4 weeks old who has been diagnosed with DMD or BMD or who is a carrier of DMD or BMD can join. Parents or legal guardians can sign up their child(ren).
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...
Frequently Asked Questions About Duchenne Muscular Dystrophy Clinical Trials
Are there duchenne muscular dystrophy clinical trials near me?
Yes, there are 39 duchenne muscular dystrophy clinical trials currently recruiting across 55+ cities in the United States, including Little Rock, Arkansas; Chicago, Illinois; Atlanta, Georgia. Browse the studies above to find one at a location convenient for you.
How do I join a duchenne muscular dystrophy clinical trial?
To join a duchenne muscular dystrophy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are duchenne muscular dystrophy clinical trials free?
Yes, participation in duchenne muscular dystrophy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of duchenne muscular dystrophy treatments are being studied?
Current duchenne muscular dystrophy clinical trials are testing a range of approaches across PHASE1 (12 studies), PHASE2 (10 studies), PHASE3 (5 studies), NA (1 study), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 34 research organizations.
Is it safe to participate in duchenne muscular dystrophy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov